GL1X · GenesisL1 explorer

Research workbench

Structure-based design of novel CHK1 inhibitors: insights into hydrogen bonding and protein-ligand affinity

Analyse Structure-based design of novel CHK1 inhibitors: insights into hydrogen bonding… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BRO
Type
protein
Length
272 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK1
EC
2.7.1.37
UniProt
O14757
Ligands
DF2
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK1 (EC 2.7.1.37)protein27232% helix, 21% strandO14757

Ligands and binding sites

  • DF2 · (2R)-3-{[(4Z)-5,6-diphenyl-6,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-ylidene]amino}propane-1,2-diol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12650.670.8329DF2
2720.360.7719empty

Compared structures

  • 2BRO · Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and… · the same entry in another collection · chain A against A, TM-score 1.00
  • O14757 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK1 (O14757) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.